Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory Roundup: Oregon Targets GNC In BMPEA Complaint, Spiked Products In Imports

This article was originally published in The Tan Sheet

Executive Summary

Oregon’s lawsuit argues GNC should not have waited for FDA warnings to remove products containing BMPEA and picamilon and violated state law by marketing products containing the ingredients at any time; and FTC “believes it is necessary for the agency to begin collecting information from e-cigarette marketers.”

You may also be interested in...



Supplement Industry Outreach To State Officials Pays Off – Former Maryland AG

State attorneys general largely are discriminating good from bad supplement industry actors, says former Maryland AG Doug Gansler following the annual meeting of the Western Attorneys General. State officials' brighter take on supplement firms stems from industry outreach and education efforts.

California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits

The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107978

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel